Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging - Perfusion differences in malignant and benign lesions

Radiology

Volumn 232, Issue 2, 2004, Pages 544-553

  Schaefer, Juergen F ^a   Vollmar, Joachim ^a   Schick, Fritz ^a   Vonthein, Reinhard ^a   Seemann, Marcus D ^a   Aebert, Herrmann ^a   Dierkesmann, Rainer ^b   Friedel, Godehard ^b   Claussen, Claus D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Schillerhoehe Hospital   (Germany)

Author keywords

Lung neoplasms, diagnosis; Lung neoplasms, MR; Lung, nodule; Magnetic resonance (MR), perfusion study

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BENIGN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LUNG NODULE; LUNG PERFUSION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COIN LESION, PULMONARY; CONTRAST MEDIA; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; LUNG DISEASES; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3242805059     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2322030515     Document Type: Article

References (52)

1. Eibel R, Turk TR, Kulinna C, Herrmann K, Reiser MF. Multidetector-row CT of the lungs: multiplanar reconstructions and maximum intensity projections for the detection of pulmonary nodules. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001; 173:815-821. [German]
2. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201:798-802.
3. Diederich S, Wormanns D, Lenzen H, Semik M, Thomas M, Peters PE. Screening for asymptomatic early bronchogenic carcinoma with low dose CT of the chest. Cancer 2000; 89:2483-2484.
4. Henschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer 2000; 89:2474-2482.
5. Swensen SJ. CT screening for lung cancer. AJR Am J Roentgenol 2002; 179:833-836.
6. Aberle DR, Gamsu G, Henschke CI, Naidich DP, Swensen SJ. A consensus statement of the Society of Thoracic Radiology: screening for lung cancer with helical computed tomography. J Thorac Imaging 2001; 16:65-68.
7. Yankelevitz DF, Gupta R, Zhao B, Henschke CI. Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology 1999; 212:561-566.
8. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217:251-256.
9. Diederich S, Lenzen H, Windmann R, et al. Pulmonary nodules: experimental and clinical studies at low-dose CT. Radiology 1999; 213:289-298.
10. Greess H, Baum U, Wolf H, et al. Dose reduction in spiral-CT: detection of pulmonary coin lesions with and without anatomically adjusted modulation of tube current. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001; 173: 466-470. [German]
11. Bernard A. Resection of pulmonary nodules using video-assisted thoracic surgery: the thorax group. Ann Thorac Surg 1996; 61:202-204.
12. Ginsberg MS, Griff SK, Go BD, Yoo HH, Schwartz LH, Panicek DM. Pulmonary nodules resected at video-assisted thoracoscopic surgery: etiology in 426 patients. Radiology 1999; 213:277-282.
13. Decamp MM. The solitary pulmonary nodule: aggressive excisional strategy. Semin Thorac Cardiovasc Surg 2002; 14:292-296.
14. Patz EF, Goodman PC. Positron emission tomography imaging of the thorax. Radiol Clin North Am 1994; 32:811-823.
15. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.
16. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914-924.
17. Mastin ST, Drane WE, Harman EM, Fenton JJ, Quesenberry L. FDG SPECT in patients with lung masses. Chest 1999; 115:1012-1017.
18. Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material-a preliminary report. Radiology 1992; 182:343-347.
19. Swensen SJ, Brown LR, Colby TV, Weaver AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995; 194:393-398.
20. Yamashita K, Matsunobe S, Takahashi R, et al. Small peripheral lung carcinoma evaluated with incremental dynamic CT: radiologic-pathologic correlation. Radiology 1995; 196:401-408.
21. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205:471-478.
22. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214:73-80.
23. Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: radiologic-pathologic correlation. J Comput Assist Tomogr 2001; 25:23-27.
24. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992; 184:687-694.
25. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 2002; 179:171-178.
26. Lauerma K, Niemi P, Hanninen H, et al. Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology 2000; 217:729-736.
27. Kvistad KA, Rydland J, Vainio J, et al. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 2000; 216:545-553.
28. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
29. Postema S, Pattynama PM, van Rijswijk CS, Trimbos JB. Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness? Radiology 1999; 210:217-220.
30. Kauczor HU, Kreitner KF. Contrast-enhanced MRI of the lung. Eur J Radiol 2000; 34:196-207.
31. Leutner C, Schild H. MRI of the lung parenchyma. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001; 173:168-175. [German]
32. Schafer JF, Vollmar J, Schick F, et al. Imaging diagnosis of solitary pulmonary nodules on an open low-field MRI system: comparison of two MR sequences with spiral CT. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002; 174: 1107-1114. [German]
33. Kono M, Adachi S, Kusumoto M, Sakai E. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging 1993; 8:18-26.
34. Hittmair K, Eckersberger F, Klepetko W, Helbich T, Herold CJ. Evaluation of solitary pulmonary nodules with dynamic contrast-enhanced MR imaging: a promising technique. Magn Reson Imaging 1995; 13:923-933.
35. Guckel C, Schnabel K, Deimling M, Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996; 200:681-686.
36. Hunter GJ, Hamberg LM, Choi N, Jain RK, McCloud T, Fischman AJ. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. Clin Cancer Res 1998; 4:949-955.
37. Li F, Sone S, Maruyama Y, et al. Correlation between high-resolution computed tomographic, magnetic resonance and pathological findings in cases with non-cancerous but suspicious lung nodules. Eur Radiol 2000; 10:1782-1791.
38. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management-initial experience. Radiology 2002; 224:503-511.
39. Browne RH. Using the sample range as a basis for calculating sample sizes in power calculations. J Tenn Acad Sci 2001; 55:293-298.
40. Dean PB, Niemi P, Kivisaari L, Kormano M. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest Radiol 1988; 23(suppl 1):S258-S260.
41. Milne EN, Noonan CD, Margulis AR, Stoughton JA. Vascular supply of pulmonary metastases: experimental study in rats. Invest Radiol 1969; 4:215-229.
42. Milne EN, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging 1987; 2:15-23.
43. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 1998; 77:440-447.
44. Chambers JS. Angiogenesis in lung cancer. Ann Thorac Surg 1998; 66:2162-2163.
45. Cox G, Jones JL, Walker RA, Steward WP, O'Byrne KJ. Angiogenesis and non-small cell lung cancer. Lung Cancer 2000; 27:81-100.
46. Duarte IG, Bufkin BL, Pennington MF, et al. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1998; 115:652-658.
47. Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997; 3:861-865.
48. Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997; 151:1417-1423.
49. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997; 7:275-280.
50. Sherif H, Mahfouz AE, Oellinger H, et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997; 205:209-213.
51. Mattern J, Koomagi R, Volm M. Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res 1999; 5:1459-1463.
52. Imoto H, Osaki T, Taga S, Ohgami A, lchiyoshi Y, Yasumoto K. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 1998; 115:1007-1014.